MyFinsight
Home
Blog
About
Short-term marketable
securities
$139,016K
(124.14%↑ Y/Y)
Cash and cash
equivalents
$44,107K
(94.46%↑ Y/Y)
Prepaid expenses and
other current assets
$3,513K
(31.03%↑ Y/Y)
Total current assets
$186,636K
(113.58%↑ Y/Y)
Long-term marketable
securities
$56,098K
(-45.38%↓ Y/Y)
Other long-term
assets
$1,649K
(20.54%↑ Y/Y)
Operating lease
right-of-use assets
$1,216K
(96.76%↑ Y/Y)
Property and equipment,
net
$695K
(121.34%↑ Y/Y)
Total assets
$246,294K
(28.02%↑ Y/Y)
Total liabilities and
stockholders' equity...
$246,294K
(28.02%↑ Y/Y)
Total stockholders'
equity (deficit)
$239,547K
(28.95%↑ Y/Y)
Total liabilities
$6,747K
(1.89%↑ Y/Y)
Accumulated deficit
-$316,947K
(-22.22%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$67K
(-121.07%↓ Y/Y)
Additional paid-in capital
$556,555K
(25.14%↑ Y/Y)
Total current
liabilities
$5,934K
(-4.37%↓ Y/Y)
Operating lease
liabilities, net of current...
$813K
(94.96%↑ Y/Y)
Common stock, 0.0001
par value...
$6K
(-14.29%↓ Y/Y)
Accrued expenses and
other current...
$4,300K
(-14.63%↓ Y/Y)
Accounts payable
$1,133K
(19.77%↑ Y/Y)
Operating lease
liabilities
$501K
(125.68%↑ Y/Y)
Back
Back
Balance Sheet
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)
source: myfinsight.com